OMB control number

Proposed Rule - Adverse Drug Experience Reporting Requirements For Marketed Prescription Drugs Without Approved New Drug Or Abbreviated New Drug Applications

OMB 0910-0210 · HHS/FDA.

OMB 0910-0210